SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study)
| Title: | SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study) |
|---|---|
| Authors: | Borghaei, Hossein, Redman, Mary W., Kelly, Karen, Waqar, Saima N., Robert, Francisco, Kiefer, Gauri J., Stella, Philip J., Minichiello, Katherine, Gandara, David R., Herbst, Roy S., Papadimitrakopoulou, Vassiliki A. |
| Source: | In Clinical Lung Cancer May 2021 22(3):178-186 |
| Database: | ScienceDirect |
| ISSN: | 15257304 |
|---|---|
| DOI: | 10.1016/j.cllc.2020.10.015 |
| Published in: | Clinical Lung Cancer |
| Language: | English |